Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Prednisone"" wg kryterium: Temat


Tytuł:
Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis.
Autorzy:
Sakkat A; Department of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia. .
Cox G; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, Ontario, Canada.
Khalidi N; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Division of Rheumatology, McMaster University, Hamilton, Ontario, Canada.
Larche M; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Division of Rheumatology, McMaster University, Hamilton, Ontario, Canada.
Beattie K; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Division of Rheumatology, McMaster University, Hamilton, Ontario, Canada.
Renzoni EA; Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK.
Morar N; Department of Dermatology, Chelsea and Westminster Hospital, London, UK.
Kouranos V; Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK.
Kolb M; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, Ontario, Canada.
Hambly N; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, Ontario, Canada.
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2022 Mar 09; Vol. 23 (1), pp. 54. Date of Electronic Publication: 2022 Mar 09.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Drug Resistance/*drug effects
Infliximab/*therapeutic use
Prednisone/*adverse effects
Sarcoidosis/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Dose-Response Relationship, Drug ; Female ; Follow-Up Studies ; Global Health ; Glucocorticoids/adverse effects ; Glucocorticoids/therapeutic use ; Humans ; Incidence ; Male ; Middle Aged ; Prednisone/therapeutic use ; Recurrence ; Retrospective Studies ; Sarcoidosis/epidemiology ; Time Factors ; Treatment Outcome ; Tumor Necrosis Factor Inhibitors/therapeutic use
Czasopismo naukowe
Tytuł:
Integrative Analysis of Gut Microbiota and Fecal Metabolites in Rats after Prednisone Treatment.
Autorzy:
Zhang J; Department of Nephrology and Rheumatology, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, China.
Feng D; Department of Nephrology and Rheumatology, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, China.
Law HK; Department of Health Technology and Informatics, Faculty of Health and Social Science, The Hong Kong Polytechnic University, Hunghom, Hong Kong, China.
Wu Y; Department of Nephrology and Rheumatology, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, China.
Zhu GH; Department of Nephrology and Rheumatology, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, China.
Huang WY; Department of Nephrology and Rheumatology, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, China.
Kang Y; Department of Nephrology and Rheumatology, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, China.
Pokaż więcej
Źródło:
Microbiology spectrum [Microbiol Spectr] 2021 Dec 22; Vol. 9 (3), pp. e0065021. Date of Electronic Publication: 2021 Nov 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-Inflammatory Agents/*adverse effects
Feces/*microbiology
Gastrointestinal Microbiome/*drug effects
Prednisone/*adverse effects
Animals ; Anti-Inflammatory Agents/administration & dosage ; Bacteria/classification ; Bacteria/drug effects ; Bacteria/genetics ; Bacteria/isolation & purification ; DNA, Bacterial/genetics ; Male ; Prednisone/administration & dosage ; RNA, Ribosomal, 16S/genetics ; Rats ; Rats, Sprague-Dawley
Czasopismo naukowe
Tytuł:
Steroid switch after progression on abiraterone plus prednisone in patients with metastatic castration-resistant prostate cancer: A systematic review.
Autorzy:
Xiong X; Department of Urology, Institute of Urology, Center of National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China.
Qiu S; Department of Urology, Institute of Urology, Center of National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China; Center of Biomedical Big Data, West China Hospital, Sichuan University, Chengdu, China.
Yi X; Department of Urology, Institute of Urology, Center of National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China.
Xu H; Department of Urology, Institute of Urology, Center of National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China.
Liao D; Department of Urology, Institute of Urology, Center of National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China.
Lei H; Department of Urology, Institute of Urology, Center of National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China.
Bai S; Department of Urology, Institute of Urology, Center of National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China.
Peng G; Department of Endocrinology and Metabolism, West China Hospital of Sichuan University, Chengdu, China.
Ai J; Department of Urology, Institute of Urology, Center of National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China. Electronic address: .
Yang L; Department of Urology, Institute of Urology, Center of National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China. Electronic address: .
Pokaż więcej
Źródło:
Urologic oncology [Urol Oncol] 2021 Nov; Vol. 39 (11), pp. 754-763. Date of Electronic Publication: 2021 Jul 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms:
Androstenes/*therapeutic use
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Prednisone/*therapeutic use
Prostatic Neoplasms, Castration-Resistant/*drug therapy
Androstenes/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Humans ; Male ; Neoplasm Metastasis ; Prednisone/pharmacology ; Progression-Free Survival ; Prostatic Neoplasms, Castration-Resistant/mortality ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Effect of pulsed intravenous methylprednisolone with alternative low-dose prednisone on high-risk IgA nephropathy: a 18-month prospective clinical trial.
Autorzy:
Li Y; Department of Nephrology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West Fifth Road, Xi'an, 710004, Shaanxi, China.
Fu R; Department of Nephrology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West Fifth Road, Xi'an, 710004, Shaanxi, China.
Gao J; Department of Nephrology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West Fifth Road, Xi'an, 710004, Shaanxi, China.
Wang L; Department of Nephrology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West Fifth Road, Xi'an, 710004, Shaanxi, China.
Duan Z; Department of Nephrology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West Fifth Road, Xi'an, 710004, Shaanxi, China.
Tian L; Department of Nephrology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West Fifth Road, Xi'an, 710004, Shaanxi, China.
Ge H; Department of Nephrology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West Fifth Road, Xi'an, 710004, Shaanxi, China.
Ma X; Department of Nephrology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West Fifth Road, Xi'an, 710004, Shaanxi, China.
Zhang Y; Department of Nephrology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West Fifth Road, Xi'an, 710004, Shaanxi, China.
Li K; Department of Nephrology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West Fifth Road, Xi'an, 710004, Shaanxi, China.
Xu P; School of Medicine, Royal College of Surgeons in Ireland, 123 St Stephen's Green, Dublin 2, Ireland.
Tian X; Section of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, 06520, USA. .
Chen Z; Department of Nephrology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West Fifth Road, Xi'an, 710004, Shaanxi, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Jan 07; Vol. 12 (1), pp. 255. Date of Electronic Publication: 2022 Jan 07.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Glomerulonephritis, IGA/*drug therapy
Glucocorticoids/*administration & dosage
Methylprednisolone/*administration & dosage
Prednisone/*administration & dosage
Proteinuria/*drug therapy
Administration, Intravenous ; Administration, Oral ; Adult ; Disease Progression ; Drug Tapering ; Drug Therapy, Combination ; Female ; Glomerulonephritis, IGA/diagnosis ; Glomerulonephritis, IGA/immunology ; Glucocorticoids/adverse effects ; Humans ; Kidney Failure, Chronic/immunology ; Kidney Failure, Chronic/prevention & control ; Male ; Methylprednisolone/adverse effects ; Prednisone/adverse effects ; Prospective Studies ; Proteinuria/diagnosis ; Proteinuria/immunology ; Pulse Therapy, Drug ; Remission Induction ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Antibodies to Full-Length Agrin Protein in Chinese Patients With Myasthenia Gravis.
Autorzy:
Wang S; Department of Neuroimmunology, Henan Institute of Medical and Pharmaceutical Sciences, Academy of Medical Science, Zhengzhou University, Zhengzhou, China.
Yang H; Department of Neuroimmunology, Henan Institute of Medical and Pharmaceutical Sciences, Academy of Medical Science, Zhengzhou University, Zhengzhou, China.; BGI College, Zhengzhou University, Zhengzhou, China.
Guo R; Department of Neurology, Tangdu Hospital, The Air Force Medical University, Xi'an, China.
Wang L; Department of Neuroimmunology, Henan Institute of Medical and Pharmaceutical Sciences, Academy of Medical Science, Zhengzhou University, Zhengzhou, China.; Department of Neurology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zhang Y; Department of Neuroimmunology, Henan Institute of Medical and Pharmaceutical Sciences, Academy of Medical Science, Zhengzhou University, Zhengzhou, China.
Lv J; Department of Neuroimmunology, Henan Institute of Medical and Pharmaceutical Sciences, Academy of Medical Science, Zhengzhou University, Zhengzhou, China.
Zhao X; Department of Neuroimmunology, Henan Institute of Medical and Pharmaceutical Sciences, Academy of Medical Science, Zhengzhou University, Zhengzhou, China.
Zhang J; Department of Neuroimmunology, Henan Institute of Medical and Pharmaceutical Sciences, Academy of Medical Science, Zhengzhou University, Zhengzhou, China.
Fang H; Department of Neuroimmunology, Henan Institute of Medical and Pharmaceutical Sciences, Academy of Medical Science, Zhengzhou University, Zhengzhou, China.
Zhang Q; Myasthenia Gravis Comprehensive Diagnosis and Treatment Center, Henan Provincial People's Hospital, Zhengzhou, China.
Zhang Y; Department of Encephalopathy, First Affiliated Hospital of Henan University of Traditional Chinese Medicine (TCM), Zhengzhou, China.
Yang J; Department of Encephalopathy, First Affiliated Hospital of Henan University of Traditional Chinese Medicine (TCM), Zhengzhou, China.
Cui X; Myasthenia Gravis Comprehensive Diagnosis and Treatment Center, Henan Provincial People's Hospital, Zhengzhou, China.
Gao P; Department of Neuroimmunology, Henan Institute of Medical and Pharmaceutical Sciences, Academy of Medical Science, Zhengzhou University, Zhengzhou, China.
Chang T; Department of Neurology, Tangdu Hospital, The Air Force Medical University, Xi'an, China.
Gao F; Department of Neuroimmunology, Henan Institute of Medical and Pharmaceutical Sciences, Academy of Medical Science, Zhengzhou University, Zhengzhou, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2021 Dec 08; Vol. 12, pp. 753247. Date of Electronic Publication: 2021 Dec 08 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Prednisone*/therapeutic use
Agrin/*immunology
Autoantibodies/*blood
Autoantigens/*immunology
Myasthenia Gravis/*immunology
Age of Onset ; Aged ; Agrin/chemistry ; Agrin/genetics ; Autoantigens/chemistry ; Autoantigens/genetics ; China/epidemiology ; Cholinesterase Inhibitors/therapeutic use ; Female ; Geography, Medical ; HEK293 Cells ; Humans ; Male ; Middle Aged ; Muscle Weakness/etiology ; Myasthenia Gravis/ethnology ; Myasthenia Gravis/etiology ; Recombinant Proteins/immunology ; Thymoma/complications ; Thymus Neoplasms/complications
Czasopismo naukowe
Tytuł:
Combined treatment of prednisone and hydroxychloroquine may improve outcomes of frozen embryo transfer in antinuclear antibody-positive patients undergoing IVF/ICSI treatment.
Autorzy:
Gao R; The Reproductive Medical Center, Department of Obstetrics and Gynecology, West China Second University Hospital, 198150Sichuan University, Chengdu, China.; West China School of Medicine, 198150Sichuan University, Chengdu, China.; Key Laboratory of Birth Defects and Related of Women and Children of Ministry of Education, West China Second University Hospital, 198150Sichuan University, Chengdu, China.
Deng W; Key Laboratory of Birth Defects and Related of Women and Children of Ministry of Education, West China Second University Hospital, 198150Sichuan University, Chengdu, China.; Information Management Department, West China Second University Hospital, 198150Sichuan University, Chengdu, China.
Meng C; Key Laboratory of Birth Defects and Related of Women and Children of Ministry of Education, West China Second University Hospital, 198150Sichuan University, Chengdu, China.; Department of Obstetrics and Gynecology, West China Second University Hospital, 198150Sichuan University, Chengdu, China.
Cheng K; Department of Outpatients, West China Second University Hospital, 198150Sichuan University, Chengdu, China.
Zeng X; The Reproductive Medical Center, Department of Obstetrics and Gynecology, West China Second University Hospital, 198150Sichuan University, Chengdu, China.; Key Laboratory of Birth Defects and Related of Women and Children of Ministry of Education, West China Second University Hospital, 198150Sichuan University, Chengdu, China.
Qin L; The Reproductive Medical Center, Department of Obstetrics and Gynecology, West China Second University Hospital, 198150Sichuan University, Chengdu, China.; Key Laboratory of Birth Defects and Related of Women and Children of Ministry of Education, West China Second University Hospital, 198150Sichuan University, Chengdu, China.
Pokaż więcej
Źródło:
Lupus [Lupus] 2021 Dec; Vol. 30 (14), pp. 2213-2220. Date of Electronic Publication: 2021 Dec 13.
Typ publikacji:
Journal Article
MeSH Terms:
Abortion, Spontaneous*
Lupus Erythematosus, Systemic*/drug therapy
Hydroxychloroquine/*pharmacology
Prednisone/*pharmacology
Antibodies, Antinuclear ; Embryo Transfer ; Female ; Fertilization in Vitro ; Humans ; Hydroxychloroquine/chemistry ; Ovulation Induction ; Prednisone/chemistry ; Pregnancy ; Pregnancy Rate ; Retrospective Studies ; Sperm Injections, Intracytoplasmic
Czasopismo naukowe
Tytuł:
Leflunomide plus low-dose prednisone in patients with progressive IgA nephropathy: a multicenter, prospective, randomized, open-labeled, and controlled trial.
Autorzy:
Ni Z; Department of Nephrology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Zhang Z; Department of Nephrology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Yu Z; Department of Nephrology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Lu F; Department of Nephrology, Huashan Hospital, Fudan University, Shanghai, China.
Mei C; Department of Nephrology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China.
Ding X; Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China.
Yuan W; Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China.
Zhang W; Department of Nephrology, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Jiang G; Department of Nephrology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Sun M; Department of Nephrology, Huadong Hospital, Fudan University, Shanghai, China.
He L; Department of Nephrology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Deng Y; Department of Nephrology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Pang H; Department of Nephrology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Qian J; Department of Nephrology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Pokaż więcej
Źródło:
Renal failure [Ren Fail] 2021 Dec; Vol. 43 (1), pp. 1214-1221.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Glomerulonephritis, IGA/*drug therapy
Immunosuppressive Agents/*therapeutic use
Leflunomide/*therapeutic use
Prednisone/*therapeutic use
Proteinuria/*drug therapy
Adult ; China ; Creatinine/blood ; Drug Therapy, Combination ; Female ; Glomerular Filtration Rate ; Glomerulonephritis, IGA/complications ; Humans ; Kidney/physiopathology ; Male ; Middle Aged ; Prednisone/administration & dosage ; Prospective Studies ; Proteinuria/etiology ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł:
Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE.
Autorzy:
Mateos MV; University Hospital of Salamanca/IBSAL, Cancer Research Center IBMCC (USAL-CSIC), Salamanca, Spain. Electronic address: .
Dimopoulos MA; National and Kapodistrian University of Athens, Athens, Greece.
Cavo M; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Istituto di Ematologia 'Seràgnoli', Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università degli Studi, Bologna, Italy.
Suzuki K; Japanese Red Cross Medical Center, Department of Hematology, Tokyo, Japan.
Knop S; Würzburg University Medical Center, Würzburg, Germany.
Doyen C; Université Catholique de Louvain, Yvoir, Belgium.
Lucio P; Champalimaud Centre for the Unknown, Lisbon, Portugal.
Nagy Z; Semmelweis Egyetem, Budapest, Hungary.
Pour L; University Hospital Brno, Brno-Bohunice-Brno-Starý Lískovec, Czech Republic.
Grosicki S; Department of Hematology and Cancer Prevention in Chorzów, Faculty of Health Sciences in Bytom, Medical University of Silesia, Katowice, Poland.
Crepaldi A; Clinica de Tratamento E, Cuiaba, Brazil.
Liberati AM; Università degli Studi di Perugia Azienda Ospedaliera 'Santa Maria,' Terni, Italy.
Campbell P; Andrew Love Cancer Centre, University Hospital Geelong, Geelong, VIC, Australia.
Yoon SS; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
Iosava G; Medinvest-Institute of Hematology, Tbilisi, Georgia.
Fujisaki T; Matsuyama Red Cross Hospital, Matsuyama, Japan.
Garg M; Leicester Royal Infirmary - Haematology, Leicester, United Kingdom.
Iida S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Mizuho-cho, Mizuho-ku Nagoya, Japan.
Bladé J; Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Ukropec J; Janssen Global Medical Affairs, Horsham, PA.
Pei H; Janssen Research & Development, LLC, Titusville, NJ.
Van Rampelbergh R; Janssen Research & Development, Beerse, Belgium.
Kudva A; Janssen Research & Development, LLC, Raritan, NJ.
Qi M; Janssen Research & Development, LLC, Spring House, PA.
San-Miguel J; Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Navarra, Spain.
Pokaż więcej
Źródło:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2021 Nov; Vol. 21 (11), pp. 785-798. Date of Electronic Publication: 2021 Jun 18.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Monoclonal/*therapeutic use
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Bortezomib/*therapeutic use
Melphalan/*therapeutic use
Multiple Myeloma/*drug therapy
Prednisone/*therapeutic use
Aged ; Aged, 80 and over ; Antibodies, Monoclonal/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Bortezomib/pharmacology ; Female ; Humans ; Male ; Melphalan/pharmacology ; Prednisone/pharmacology
Czasopismo naukowe
Tytuł:
ABCL-023 frontMIND: A Phase III, Randomized, Double-Blind Study of Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP Alone for Newly Diagnosed High-Intermediate and High-Risk Diffuse Large B-Cell Lymphoma.
Autorzy:
Vitolo U; Candiolo Cancer Institute, FPO-IRCCS, Candiolo (Torino), Italy.
Nowakowski GS; Division of Hematology, Mayo Clinic, Rochester, USA.
Burke JM; Department of Hematology, US Oncology Research and Rocky Mountain Cancer Centers, Aurora, USA.
Fox CP; Department of Clinical Hematology, Nottingham University Hospitals NHS, Nottingham, United Kingdom.
Trneny M; 1st Department of Medicine, First Medical Faculty, Charles University and General University Hospital, Prague, Czech Republic.
Chiappella A; Division of Hematology & Stem Cell Transplant, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milano, Italy.
Waldron-Lynch M; MorphoSys US, Inc., Boston, USA.
Hadar N; MorphoSys US, Inc., Boston, USA.
Pachori A; MorphoSys US, Inc., Boston, USA.
Lenz G; Department of Medicine A - Hematology and Oncology, University Hospital Münster, Münster, Germany.
Pokaż więcej
Źródło:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2022 Oct; Vol. 22 Suppl 2, pp. S352-S353.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Lymphoma, Large B-Cell, Diffuse*/diagnosis
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Lymphoma, Non-Hodgkin*/drug therapy
Antibodies, Monoclonal, Humanized ; Antibodies, Monoclonal, Murine-Derived/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cyclophosphamide/pharmacology ; Cyclophosphamide/therapeutic use ; Double-Blind Method ; Doxorubicin/adverse effects ; Humans ; Lenalidomide/pharmacology ; Lenalidomide/therapeutic use ; Neoplasm Recurrence, Local/drug therapy ; Prednisone/pharmacology ; Prednisone/therapeutic use ; Rituximab/pharmacology ; Rituximab/therapeutic use ; Treatment Outcome ; Vincristine/adverse effects
Czasopismo naukowe
Tytuł:
ABCL-022 Pharmacokinetics and Pharmacodynamics in First-MIND: A Phase Ib, Open-Label, Randomized Study of Tafasitamab ± Lenalidomide + R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma.
Autorzy:
Belada D; 4th Department of Internal Medicine - Hematology, University Hospital and Faculty of Medicine, Hradec Králové, Czech Republic.
Kopeckova K; Department of Oncology of the 2nd Faculty of Medicine of Charles University and Motol University Hospital, Praha, Czech Republic.
Burgues JMB; Department of Hematology, Hospital San Pedro de Alcantara, Cáceres, Spain.
Stevens D; Norton Cancer Institute - St. Matthews Campus, 3991 Dutchmans Lane, 40207, Louisville, USA.
Nowakowski GS; Division of Hematology, Mayo Clinic, Rochester, USA.
Waldron-Lynch M; MorphoSys US, Inc., Boston, USA.
Hadar N; MorphoSys US, Inc., Boston, USA.
Weirather J; MorphoSys AG, Planegg, Germany.
Lässig C; MorphoSys AG, Planegg, Germany.
Blair D; MorphoSys AG, Planegg, Germany.
Dreyling M; Medical Clinic III, University Clinic, Ludwig-Maximilians-University Hospital, Munich, Germany.
Pokaż więcej
Źródło:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2022 Oct; Vol. 22 Suppl 2, pp. S352.
Typ publikacji:
Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols*/pharmacology
Antineoplastic Combined Chemotherapy Protocols*/therapeutic use
Lymphoma, Large B-Cell, Diffuse*/pathology
Adult ; Antibodies, Monoclonal, Murine-Derived/therapeutic use ; Cyclophosphamide/pharmacology ; Cyclophosphamide/therapeutic use ; Doxorubicin/pharmacology ; Doxorubicin/therapeutic use ; Humans ; Lenalidomide/pharmacology ; Lenalidomide/therapeutic use ; Prednisone/pharmacology ; Prednisone/therapeutic use ; Rituximab/pharmacology ; Rituximab/therapeutic use ; Treatment Outcome ; Vincristine/pharmacology ; Vincristine/therapeutic use
Czasopismo naukowe
Tytuł:
Insight into glucocorticoids glucosylation by glucosyltransferase: A combined experimental and in-silico approach.
Autorzy:
Subedi P; Department of Life Science and Biochemical Engineering, Sunmoon University, 70 Sunmoon-ro 221, Tangjeong-myeon, Asan-si, Chungnam 31460, Republic of Korea.
Kim MS; Department of Life Science and Biochemical Engineering, Sunmoon University, 70 Sunmoon-ro 221, Tangjeong-myeon, Asan-si, Chungnam 31460, Republic of Korea.
Lee JH; Genome-based BioIT Convergence Institute, 70 Sunmoon-ro 221, Tangjeong-myeon, Asan-si, Chungnam 31460, Republic of Korea; Department of BT-Convergent Pharmaceutical Engineering, Sunmoon University, 70 Sunmoon-ro 221, Tangjeong-myeon, Asan-si, Chungnam 31460, Republic of Korea.
Park JK; Department of Biomedical Science and Research Institute for Bioscience & Biotechnology, Hallym University, 1 Hallymdaehak-gil, Chuncheon, Gangwon-do 24252, Republic of Korea.
Oh TJ; Department of Life Science and Biochemical Engineering, Sunmoon University, 70 Sunmoon-ro 221, Tangjeong-myeon, Asan-si, Chungnam 31460, Republic of Korea; Genome-based BioIT Convergence Institute, 70 Sunmoon-ro 221, Tangjeong-myeon, Asan-si, Chungnam 31460, Republic of Korea; Department of BT-Convergent Pharmaceutical Engineering, Sunmoon University, 70 Sunmoon-ro 221, Tangjeong-myeon, Asan-si, Chungnam 31460, Republic of Korea. Electronic address: .
Pokaż więcej
Źródło:
Biophysical chemistry [Biophys Chem] 2022 Oct; Vol. 289, pp. 106875. Date of Electronic Publication: 2022 Aug 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cortisone*
Glucosyltransferases*/chemistry
Glucosyltransferases*/metabolism
Glucocorticoids ; Glucose ; Glucosides ; Prednisone
Czasopismo naukowe
Tytuł:
Steroid affected cytokines in aspirin-exacerbated respiratory disease.
Autorzy:
Tan LH; Department of Otorhinolaryngology-Head and Neck Surgery, Division of Rhinology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Lin C; Monell Chemical Senses Center, Philadelphia, Pennsylvania, USA.
Ungerer H; Department of Otorhinolaryngology-Head and Neck Surgery, Division of Rhinology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Kumar A; Department of Otorhinolaryngology-Head and Neck Surgery, Division of Rhinology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Qatanani A; Drexel School of Medicine, Philadelphia, Pennsylvania, USA.
Adappa ND; Department of Otorhinolaryngology-Head and Neck Surgery, Division of Rhinology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Palmer JN; Department of Otorhinolaryngology-Head and Neck Surgery, Division of Rhinology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Bosso JV; Department of Otorhinolaryngology-Head and Neck Surgery, Division of Rhinology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Reed D; Monell Chemical Senses Center, Philadelphia, Pennsylvania, USA.
Cohen NA; Department of Otorhinolaryngology-Head and Neck Surgery, Division of Rhinology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; Monell Chemical Senses Center, Philadelphia, Pennsylvania, USA.; Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA.
Kohanski MA; Department of Otorhinolaryngology-Head and Neck Surgery, Division of Rhinology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Pokaż więcej
Źródło:
International forum of allergy & rhinology [Int Forum Allergy Rhinol] 2022 Oct; Vol. 12 (10), pp. 1232-1241. Date of Electronic Publication: 2022 Jan 24.
Typ publikacji:
Journal Article
MeSH Terms:
Asthma, Aspirin-Induced*/drug therapy
Nasal Polyps*/drug therapy
Sinusitis*/chemically induced
Aspirin/adverse effects ; Cytokines ; Granulocyte-Macrophage Colony-Stimulating Factor ; Humans ; Interleukin-10 ; Interleukin-13 ; Interleukin-17 ; Interleukin-33 ; Interleukin-4 ; Interleukin-5 ; Interleukin-6 ; Lipids ; Prednisone/therapeutic use ; Tumor Necrosis Factor-alpha
Czasopismo naukowe
Tytuł:
Iatrogenic Cushing syndrome in 24-hour urine free cortisol measurement.
Autorzy:
Ray JA; ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT 84108, United States. Electronic address: .
Bajaj AO; ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT 84108, United States.
Trier EK; ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT 84108, United States.
Johnson LM; ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT 84108, United States; Department of Pathology, University of Utah, Salt Lake City, UT 84108, United States.
Pokaż więcej
Źródło:
Clinica chimica acta; international journal of clinical chemistry [Clin Chim Acta] 2022 Sep 01; Vol. 534, pp. 173-175. Date of Electronic Publication: 2022 Aug 02.
Typ publikacji:
Journal Article
MeSH Terms:
Cushing Syndrome*/chemically induced
Cushing Syndrome*/diagnosis
Chromatography, Liquid/methods ; Glucocorticoids ; Humans ; Hydrocortisone ; Iatrogenic Disease ; Prednisolone ; Prednisone ; Tandem Mass Spectrometry/methods
Czasopismo naukowe
Tytuł:
Chronic endometritis in recurrent implantation failure: Use of prednisone and IVF outcome.
Autorzy:
Giulini S; Unit of Reproductive Medicine, Institute of Obstetrics and Gynecology, Mother Infant Department, University Hospital Policlinico of Modena, 41125 Modena, Italy. Electronic address: .
Grisendi V; Unit of Reproductive Medicine, Institute of Obstetrics and Gynecology, Mother Infant Department, University Hospital Policlinico of Modena, 41125 Modena, Italy.
Sighinolfi G; Unit of Reproductive Medicine, Institute of Obstetrics and Gynecology, Mother Infant Department, University Hospital Policlinico of Modena, 41125 Modena, Italy.
Di Vinci P; Department of Biomedical, Metabolic and Neural Sciences, International Doctorate School in Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy.
Tagliasacchi D; Unit of Reproductive Medicine, Institute of Obstetrics and Gynecology, Mother Infant Department, University Hospital Policlinico of Modena, 41125 Modena, Italy.
Botticelli L; Institute of Anatomy and Histology Pathology, Department of Laboratory Medicine and Anatomy Pathology, University Hospital Policlinico of Modena, 41125 Modena, Italy.
La Marca A; Unit of Reproductive Medicine, Institute of Obstetrics and Gynecology, Mother Infant Department, University Hospital Policlinico of Modena, 41125 Modena, Italy.
Facchinetti F; Unit of Reproductive Medicine, Institute of Obstetrics and Gynecology, Mother Infant Department, University Hospital Policlinico of Modena, 41125 Modena, Italy.
Pokaż więcej
Źródło:
Journal of reproductive immunology [J Reprod Immunol] 2022 Sep; Vol. 153, pp. 103673. Date of Electronic Publication: 2022 Jul 14.
Typ publikacji:
Journal Article
MeSH Terms:
Endometritis*/drug therapy
Endometritis*/pathology
Anti-Bacterial Agents/therapeutic use ; Chronic Disease ; Female ; Fertilization in Vitro/adverse effects ; Humans ; Prednisone/therapeutic use ; Pregnancy ; Pregnancy Rate ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Patient characteristics and outcome of CD20-positive HIV-associated lymphoma: a single-center KwaZulu-Natal, South African hospital 12-year retrospective review.
Autorzy:
Rapiti N; Department of Haematology, NHLS/University of KwaZulu Natal/King Edward VIII Hospital, Durban, South Africa. .
Abdelatif N; Biostatistics Research Unit, South African Medical Research Council, Durban, South Africa.
Rapiti A; Department of Neurosurgery, Inkosi Albert Luthuli Central Hospital, Durban, South Africa.
Moosa MY; Department of Infectious Diseases, University of KwaZulu-Natal, Durban, South Africa.
Pokaż więcej
Źródło:
Journal of the Egyptian National Cancer Institute [J Egypt Natl Canc Inst] 2022 Aug 01; Vol. 34 (1), pp. 32. Date of Electronic Publication: 2022 Aug 01.
Typ publikacji:
Journal Article; Review
MeSH Terms:
HIV Infections*/epidemiology
Lymphoma*/chemically induced
Lymphoma*/drug therapy
Lymphoma*/epidemiology
Adult ; Antibodies, Monoclonal, Murine-Derived/adverse effects ; Antibodies, Monoclonal, Murine-Derived/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cyclophosphamide/therapeutic use ; Doxorubicin/adverse effects ; Doxorubicin/therapeutic use ; Female ; HIV ; Hospitals ; Humans ; Lymphoma, Large B-Cell, Diffuse/drug therapy ; Male ; Prednisone/adverse effects ; Prednisone/therapeutic use ; Retrospective Studies ; Rituximab/therapeutic use ; South Africa/epidemiology ; Treatment Outcome ; Vincristine/therapeutic use
Czasopismo naukowe
Tytuł:
Impact of circadian time of dosing on cardiomyocyte-autonomous effects of glucocorticoids.
Autorzy:
Wintzinger M; Division of Molecular Cardiovascular Biology, Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Panta M; Division of Molecular Cardiovascular Biology, Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Miz K; Division of Molecular Cardiovascular Biology, Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Prabakaran AD; Division of Molecular Cardiovascular Biology, Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Durumutla HB; Division of Molecular Cardiovascular Biology, Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; Department of Pediatrics, University of Cincinnati College of Medicine; Cincinnati, OH, USA.
Sargent M; Division of Molecular Cardiovascular Biology, Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Peek CB; Division of Endocrinology, Metabolism and Molecular Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA; Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Bass J; Division of Endocrinology, Metabolism and Molecular Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Molkentin JD; Division of Molecular Cardiovascular Biology, Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; Department of Pediatrics, University of Cincinnati College of Medicine; Cincinnati, OH, USA.
Quattrocelli M; Division of Molecular Cardiovascular Biology, Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; Department of Pediatrics, University of Cincinnati College of Medicine; Cincinnati, OH, USA. Electronic address: .
Pokaż więcej
Źródło:
Molecular metabolism [Mol Metab] 2022 Aug; Vol. 62, pp. 101528. Date of Electronic Publication: 2022 Jun 16.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Circadian Clocks*/physiology
Heart Failure*/metabolism
Animals ; Glucocorticoids/metabolism ; Glucocorticoids/pharmacology ; Mice ; Myocytes, Cardiac/metabolism ; Prednisone/metabolism ; Prednisone/pharmacology
Czasopismo naukowe
Tytuł:
The efficacy of low dose short-term prednisone therapy for remission induction in newly diagnosed rheumatoid arthritis patients.
Autorzy:
Stacy JM; University of North Dakota School of Medicine and Health Sciences, Grand Forks, ND, USA.
Greenmyer JR; University of North Dakota School of Medicine and Health Sciences, Grand Forks, ND, USA.
Beal JR; Department of Family and Community Medicine, University of North Dakota School of Medicine and Health Sciences, Grand Forks, ND, USA.
Sahmoun AE; Department of Internal Medicine, University of North Dakota School of Medicine and Health Sciences, Forks, ND, USA.
Diri E; Division of Rheumatology, Trinity Medical Group, Minot, ND, USA. .
Pokaż więcej
Źródło:
Advances in rheumatology (London, England) [Adv Rheumatol] 2021 Aug 09; Vol. 61 (1), pp. 50. Date of Electronic Publication: 2021 Aug 09.
Typ publikacji:
Journal Article
MeSH Terms:
Arthritis, Rheumatoid*/diagnosis
Arthritis, Rheumatoid*/drug therapy
Glucocorticoids*/administration & dosage
Prednisone*/administration & dosage
Humans ; Remission Induction ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Case report: Joint deformity associated with systemic lupus erythematosus.
Autorzy:
Chen SL; Department of Rheumatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.; The First Clinical Medicine School, Guangzhou University of Chinese Medicine, Guangzhou, China.
Zheng HJ; Department of Rheumatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.; The First Clinical Medicine School, Guangzhou University of Chinese Medicine, Guangzhou, China.
Zhang LY; Department of Rheumatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.; The First Clinical Medicine School, Guangzhou University of Chinese Medicine, Guangzhou, China.
Xu Q; Department of Rheumatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.; The First Clinical Medicine School, Guangzhou University of Chinese Medicine, Guangzhou, China.
Lin CS; Department of Rheumatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.; The First Clinical Medicine School, Guangzhou University of Chinese Medicine, Guangzhou, China.
Pokaż więcej
Źródło:
Immunity, inflammation and disease [Immun Inflamm Dis] 2022 Oct; Vol. 10 (10), pp. e717.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Arthritis, Rheumatoid*/complications
Arthritis, Rheumatoid*/pathology
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/diagnosis
Lupus Erythematosus, Systemic*/drug therapy
Adult ; Antibodies, Antinuclear ; Antigens, Nuclear ; C-Reactive Protein ; Celecoxib ; Complement C3 ; DNA ; Female ; Humans ; Methotrexate ; Prednisone
SCR Disease Name:
rhupus syndrome
Czasopismo naukowe
Tytuł:
ABCL-242 Definition of Bulky Disease in Early-Stage Diffuse Large B-Cell Lymphoma on Longitudinal and Axial Planes.
Autorzy:
Ma'koseh M; King Hussein Cancer Center, Amman, Jordan.
Khater S; King Hussein Cancer Center, Amman, Jordan.
Farfoura H; King Hussein Cancer Center, Amman, Jordan.
Khatib Y; King Hussein Cancer Center, Amman, Jordan.
Omari Z; King Hussein Cancer Center, Amman, Jordan.
Ababneh H; King Hussein Cancer Center, Amman, Jordan.
Faiyoumi B; King Hussein Cancer Center, Amman, Jordan.
Taqash A; King Hussein Cancer Center, Amman, Jordan.
Abufara A; King Hussein Cancer Center, Amman, Jordan.
Shahin O; King Hussein Cancer Center, Amman, Jordan.
Saleh Y; King Hussein Cancer Center, Amman, Jordan.
Halahleh K; King Hussein Cancer Center, Amman, Jordan.
Alrabi K; King Hussein Cancer Center, Amman, Jordan.
Pokaż więcej
Źródło:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2022 Oct; Vol. 22 Suppl 2, pp. S365.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols*/therapeutic use
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Lymphoma, Large B-Cell, Diffuse*/therapy
Cyclophosphamide/therapeutic use ; Doxorubicin/therapeutic use ; Humans ; Middle Aged ; Neoplasm Recurrence, Local ; Prednisone/therapeutic use ; Prognosis ; Retrospective Studies ; Rituximab/therapeutic use ; Survival Analysis ; Vincristine/therapeutic use
Czasopismo naukowe
Tytuł:
MPN-166 Myeloproliferative Neoplasm (MPN) Post-Renal Transplant (RT)-A Single-Center Review.
Autorzy:
Thomas N; UTMcGovern Medical School at Houston, Houston, USA.
Yohannan B; UTMcGovern Medical School at Houston, Houston, USA.
Sridhar A; UTMcGovern Medical School at Houston, Houston, USA.
Rios A; UTMcGovern Medical School at Houston, Houston, USA.
Pokaż więcej
Źródło:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2022 Oct; Vol. 22 Suppl 2, pp. S328.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Kidney Transplantation*/adverse effects
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy
Polycythemia Vera*/drug therapy
Aspirin/therapeutic use ; Dasatinib/therapeutic use ; Female ; Fusion Proteins, bcr-abl/genetics ; Humans ; Hydroxyurea/therapeutic use ; Imatinib Mesylate/therapeutic use ; Middle Aged ; Mutation ; Prednisone/therapeutic use ; Protein Kinase Inhibitors/therapeutic use ; Retrospective Studies ; Tacrolimus/therapeutic use
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz